FI904345A0 - Syntetisk peptidantigen foer detektering av htlv-1 infektion. - Google Patents

Syntetisk peptidantigen foer detektering av htlv-1 infektion.

Info

Publication number
FI904345A0
FI904345A0 FI904345A FI904345A FI904345A0 FI 904345 A0 FI904345 A0 FI 904345A0 FI 904345 A FI904345 A FI 904345A FI 904345 A FI904345 A FI 904345A FI 904345 A0 FI904345 A0 FI 904345A0
Authority
FI
Finland
Prior art keywords
htlv
peptidantigen
infektion
synthetic
detecting
Prior art date
Application number
FI904345A
Other languages
English (en)
Inventor
Vahlne Anders
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Virovahl Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virovahl Sa filed Critical Virovahl Sa
Publication of FI904345A0 publication Critical patent/FI904345A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
FI904345A 1988-03-10 1990-09-03 Syntetisk peptidantigen foer detektering av htlv-1 infektion. FI904345A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16620588A 1988-03-10 1988-03-10
US07/206,140 US5017687A (en) 1988-03-10 1988-06-13 Peptides for the detection of HTLV-1 infection
PCT/SE1989/000126 WO1989008664A1 (en) 1988-03-10 1989-03-10 Synthetic peptide antigens for the detection of htlv-1 infection

Publications (1)

Publication Number Publication Date
FI904345A0 true FI904345A0 (fi) 1990-09-03

Family

ID=26862056

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904345A FI904345A0 (fi) 1988-03-10 1990-09-03 Syntetisk peptidantigen foer detektering av htlv-1 infektion.

Country Status (10)

Country Link
US (1) US5017687A (fi)
EP (1) EP0403568B1 (fi)
JP (1) JPH0751598B2 (fi)
KR (1) KR900700507A (fi)
AT (1) ATE107663T1 (fi)
CA (1) CA1336529C (fi)
DE (1) DE68916421T2 (fi)
FI (1) FI904345A0 (fi)
NZ (1) NZ228302A (fi)
WO (1) WO1989008664A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
US5322769A (en) * 1988-03-11 1994-06-21 Abbott Laboratories Methods for using CKS fusion proteins
SE8900721D0 (sv) 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
SE467542B (sv) * 1989-06-13 1992-08-03 Syntello Ab Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
US5882853A (en) * 1989-09-01 1999-03-16 The United States Of America As Represented By The Department Of Health And Human Services Method of evaluating HTLV-I-specific T cell responses
US5283320A (en) * 1989-11-13 1994-02-01 Syntello Ab Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom
FI910245A (fi) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot htlv-antikroppar.
NZ238855A (en) * 1990-07-18 1994-03-25 Iaf Biochem Int Peptides, mixtures thereof and compositions useful for detecting htlv-i and htlv-ii infections
US5378805A (en) * 1990-08-29 1995-01-03 United States Of America Immunoreactive HTLV-I/II ENV and POL peptides
JPH07502483A (ja) * 1990-08-29 1995-03-16 アメリカ合衆国 新規ペプチド抗原およびそれを用いるイムノアッセイ、試験キットおよびワクチン
EP0555405A4 (en) * 1990-10-26 1993-08-25 The President And Fellows Of Harvard College Specific detection of antibodies to human t-cell leukemia viruses
JP3421336B2 (ja) * 1991-07-10 2003-06-30 アボツト・ラボラトリーズ 合成ペプチドを用いてのｈｔｌｖ−▲ｉ▼とｈｔｌｖ−▲ｉｉ▼との区別
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
WO1993002102A1 (en) * 1991-07-23 1993-02-04 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Novel peptide antigens and immunoassays, test kits and vaccines using the same
US5736378A (en) * 1991-09-12 1998-04-07 The Scripps Research Institute Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
CA2117378C (en) * 1992-02-24 2003-04-15 Steven K. H. Foung Htlv-i/htlv-ii assay and method
SE9202318L (sv) * 1992-08-10 1994-02-11 Replico Medical Ab Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
AU6764196A (en) * 1995-08-31 1997-03-19 First Medical, Inc. Methods and antibodies for detecting creatine kinase
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
JP2008504216A (ja) * 2003-12-02 2008-02-14 サイトイミューン サイエンシズ インコーポレイテッド モノクローナル抗体の生成のための方法および組成物
JP4833862B2 (ja) * 2004-01-28 2011-12-07 サイトイミューン サイエンシズ インコーポレイテッド 官能化コロイド金属組成物および方法
WO2005076002A1 (ja) * 2004-02-06 2005-08-18 Kyowa Medex Co., Ltd. 抗体の測定方法
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
AU2008302035A1 (en) * 2007-09-21 2009-03-26 Cytimmune Sciences, Inc. Nanotherapeutic colloidal metal compositions and methods
WO2009062151A1 (en) 2007-11-08 2009-05-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028993A (ja) * 1983-07-22 1985-02-14 Otsuka Pharmaceut Co Ltd ヒト白血病ウイルス関連ペプチド
JPS60142925A (ja) * 1983-12-28 1985-07-29 Japan Found Cancer ヒト白血病ウイルス抗体の製造法
EP0152030A3 (en) * 1984-02-03 1986-08-13 Juridical Foundation Japanese Foundation for Cancer Research Adult t cell leukemia virus antigen polypeptide
JPS60249058A (ja) * 1984-05-25 1985-12-09 Eisai Co Ltd Ａｔｌウイルス抗体の測定方法および試薬
US4722888A (en) * 1985-03-29 1988-02-02 United States Of America As Represented By The Department Of Health And Human Services Cell line producing human monoclonal antibody which binds to HTLV-I producing cells
JP2564268B2 (ja) * 1985-08-28 1996-12-18 協和醗酵工業株式会社 融合抗原ポリペプチド
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
EP0246101A3 (en) * 1986-05-14 1989-06-07 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Protein having htlv-1 antigenic activity and preparation thereof

Also Published As

Publication number Publication date
DE68916421D1 (de) 1994-07-28
WO1989008664A1 (en) 1989-09-21
KR900700507A (ko) 1990-08-13
CA1336529C (en) 1995-08-01
JPH03503284A (ja) 1991-07-25
JPH0751598B2 (ja) 1995-06-05
EP0403568A1 (en) 1990-12-27
ATE107663T1 (de) 1994-07-15
DE68916421T2 (de) 1994-11-24
NZ228302A (en) 1990-12-21
EP0403568B1 (en) 1994-06-22
US5017687A (en) 1991-05-21

Similar Documents

Publication Publication Date Title
FI904345A0 (fi) Syntetisk peptidantigen foer detektering av htlv-1 infektion.
DK268588A (da) Syntetisk peptidantigen til detektering af hiv-2-infektion
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
DK0891982T3 (da) HIV-peptider
NO870412L (no) Peptider.
DE69026554D1 (de) Erfassung von undurchsichtigen Fremdartikeln unter durchsichtigen Körpern
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
SE8902148L (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
ES2032447T3 (es) Nuevos anticuerpos monoclonales y su produccion y uso.
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
DE69026875T2 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
FI904636A0 (fi) Antikroppar mot hoegkonserverade aminosyrasekvenser av immunogena aemnen, foerfarande foer framstaellning av dessa antikroppar och deras anvaendning vid immunbestaemning.
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
NO903760D0 (no) Syntetiske peptid antigener for detektering av htlv-1 infeksjon.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: SYNTELLO AB